Figure 2From: Dose escalation to high-risk sub-volumes based on non-invasive imaging of hypoxia and glycolytic activity in canine solid tumors: a feasibility study Sub-volume fraction of the total GTV for 64 Cu-ATSM (Cu3), FDG40 and FDG50. Back to article page